What is NDC 0990-7965?

0990-7965 is the product NDC for Normosol-M And Dextrose, Dextrose monohydrate 5 g/100mL + 3 more ingredients injection, solution, listed with the FDA by ICU Medical Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Normosol-M And Dextrose (Dextrose monohydrate, sodium chloride, potassium acetate, and magnesium acetate).

What is the active ingredient?

Dextrose monohydrate, Sodium chloride, Potassium acetate, Magnesium acetate.

ICU Medical Inc., NDC labeler code 0990. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Normosol-M And Dextrose?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Normosol-M And Dextrose NDC 0990-7965 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0990-7965Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00990-7965Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0990-7965-09	00990796509	12 POUCH in 1 CASE (0990-7965-09) / 1 BAG in 1 POUCH / 1000 mL in 1 BAGMarketed from Feb 8, 2021

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Normosol-M And Dextrose
Generic name (nonproprietary): dextrose monohydrate, sodium chloride, potassium acetate, and magnesium acetate
Active ingredients: Dextrose monohydrate — 5 g/100mLSodium chloride — 234 mg/100mLPotassium acetate — 128 mg/100mLMagnesium acetate — 21 mg/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: ICU Medical Inc.NDC labeler code 0990
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 017610
Marketing start: Feb 8, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 0990-7965_4c144127-6bca-4067-8d7a-75859a8e2aa5SPL ID 4c144127-6bca-4067-8d7a-75859a8e2aa5SPL set ID aba60c84-94d9-46d0-bdbb-25e0c4e8cc41RxCUI 801005, 801009UNII LX22YL083G, 451W47IQ8X, M911911U02, 0E95JZY48K
Pharmacologic class: Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400990796509 followed by a unit qualifier and the quantity

Package 00990-7965-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 24, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Normosol-M and 5% Dextrose Injection (Multiple Electrolytes and 5% Dextrose Injection Type 1, USP) is indicated for parenteral maintenance of routine daily fluid and electrolyte requirements with minimal carbohydrate calories from dextrose. Magnesium in the formula may help to prevent iatrogenic magnesium deficiency in patients receiving prolonged parenteral therapy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0990-7965

What is NDC 0990-7965?: 0990-7965 is the product NDC for Normosol-M And Dextrose, Dextrose monohydrate 5 g/100mL + 3 more ingredients injection, solution, listed with the FDA by ICU Medical Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Normosol-M And Dextrose (Dextrose monohydrate, sodium chloride, potassium acetate, and magnesium acetate).
What is the active ingredient?: Dextrose monohydrate, Sodium chloride, Potassium acetate, Magnesium acetate.
Who is the labeler?: ICU Medical Inc., NDC labeler code 0990. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Normosol-M And Dextrose?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.